神经内分泌瘤的分子成像:当前的应用和未来的趋势
Ivan E Wang1, Helen A SaTsu1, Allen F Brooks1
1Department of Radiology, University of Michigan, Ann Arbor MI 48109 USA.
Diagnostic and interventional imaging
|May 22, 2025
概括
神经内分泌瘤 (NEN) 成像正在推进,新的放射性药物针对特定的受体和代谢途径. 新兴药物承诺为NEN患者提供更个性化的诊断和治疗策略.
科学领域:
- 核医学就是核医学.
- 在瘤学瘤学.
- 放射性药物科学 放射性药物科学
背景情况:
- 神经内分泌瘤 (NENs),包括神经内分泌瘤 (NETs) 和神经内分泌癌 (NECs),患病率越来越高.
- 诊断成像剂的进步,特别是正子发射断层扫描 (PET) 和单光子发射计算断层扫描 (SPECT),正在推动NENs的新型放射性药物的开发.
研究的目的:
- 为了回顾NEN成像剂的当前景观.
- 讨论新兴放射性药物及其对个性化NEN管理的潜力.
主要方法:
- 对针对NEN特定途径的现有和正在研究的成像剂的分析.
- 对向索马托斯塔丁受体,北上腺素运输,氨基酸运输,葡萄糖类-1受体和葡萄糖代谢的药物的审查.
- 对特定的NEN亚型的药物的评估,如胃肠道胰腺 NETs,血红细胞瘤,偏角质瘤,神经母细胞瘤,胰岛素瘤,髓性甲状腺癌和差异化NEN/NEC.
主要成果:
- 已建立的药物,如[68Ga]DOTATATE,[131I]MIBG和[18F]FDOPA,用于特定的NEN类型.
- [18F]二氧化糖和[68Ga]纤维细胞激活蛋白抑制剂-04用于差异化的NEN/NEC.
- 目前正在开发新兴药物,针对体静止素受体对抗剂,bombesin受体2,CXCR4和GIPR.
结论:
- 针对性的放射性药物的开发对于个性化的NEN成像和管理至关重要.
- 一些新型药物正在开发中,显示未来临床应用在NEN诊断和风险分层中的希望.
- 需要进一步的研究来确定这些新兴药物的全部临床效用.
更多相关视频
10:04Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
Published on: March 13, 2018
12.2K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.1K
相关概念视频
Brain Imaging
325
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
325
Imaging Studies II: Positron Emission Tomography and Scintigraphy
244
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
244
Positron Emission Tomography
5.9K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
5.9K
